Ali Akbar Firasi 22010112130059 Lap.KTI Bab7
34
DAFTAR PUSTAKA
1.
Komite Nasional Penanggulangan Kanker (KPKN). 2015. Panduan Nasional
Penanganan Kanker Payudara. Kementrian Kesehatan Republik Indonesia.
2.
Anggorowati, Linda. 2013. Faktor Risiko Kanker Payudara Wanita. Jurnal
Kesehatan Masyarakat. Vol 8, No.2.
3.
Alteri, Rick. 2013. Breast Cancer Facts & Figures. Atlanta : Amercian Cancer
Society.
4.
Harianto. 2005. Risiko Penggunaan Pil Kontrasepsi Kombinasi Terhadap
Kejadian Kanker Payudara Pada Reseptor KB Di Perjan RS Dr. Cipto
Mangunkusumo. Majalah Ilmu Kefarmasian. Vol 2, No.1.
5.
Elisabet, Surbakti. 2013. Hubungan Riwayat Keturunan Dengan Terjadinya
Kanker Payu- dara Pada Ibu Di RSUP H . Adam Malik Medan The Relationship
Between Heredity And Incident Of Breast Can- cer Among Mothers At RSUP
H . Adam Malik , Medan.
6.
Kumar, V. dkk. 2013. Robbins Basic Pathology Edisi ke-9. Canada : Elsevier.
7.
Lakhani, S., dkk. 2012. WHO Classification of Tumours of the Breast.
International Agency for Research On Cancer.
8.
K. Anders, Carey, dkk. 2009. Breast Cancer Before Age 40 Years. NIH Public
Access Semioncol vol 36, pp. 237-49.
9.
Assi, Hussein A., dkk. 2013. Epidemiology and prognosis of breast cancer in
youg women. American University of Beirut Medical Center Lebanon.
35
10.
Rosai, J. 2011. Rosai And Ackerman Surgical Pathology 10th ed. Vol 2.
Philadelphia : Elseiver Sanders.
11.
Maru, D., dkk. 2005. HER-2 / neu and p53 Overexpression As Biomarkers of
Breast Carcinoma in Women Age 30 Years and Younger. American Cancer
Society.
12.
Han, W., dkk. 2004. Young age : an independent risk factor for survival in
women with operable breast cancer. BioMedCentral. Vol 4, No. 82.
13.
Constantines, Paris. 1994. General Pathobiology. Appleton & Lange.
14.
Duarsa, D.P., dkk. 2013. Faktor Risiko Kanker Payudara Pada Wanita di RSUP
Sanglah Denpasar. Denpasar : Universitas Udayana.
15.
Payne, S., dkk. 2008. Predictive markers in breast cancer - The Present.
16.
Your Guide to the Breast Cancer Pathology Report. Available From :
http://www.breastcancer.org/cms_files/47/Breastcancerorg_Pathology_Report_
Guide_2014.pdf.
17.
Upadana, I Nyoman. 2013. Ekspresi Cyclooxygenase-2 Berhubungan Positif
Dengan Derajat Diferensiasi Karsinoma Payudara Duktal Invasif Tipe Tidak
Spesifik. Universitas Udayana.
18.
Conzen, Suzanne D., Grushko, Tatyana A., dan Olopade, Olufunmilayo I. 2008.
Cancer of the Breast. Dalam DeVita, Vincent T., Lawrence, Theodore S., dan
Rosenberg, Steven A., Cancer Principles & Practice of Oncology Edisi ke-8.
Lippincott Williams & Wilkin.
19.
Nishimura, R., dkk. 2010. Ki-67 as a prognostic marker according to breast
36
cancer subtype and a predictor of recurrence time in primary breast cancer.
Experimental And Therapeutic Medicine. Vol 1, p 747-754.
20.
Klintmant, M. dkk. 2012. The Prognostic Value of Mitotic Activity Index
( MAI ), Phosphohistone H3 ( PPH3 ), Cyclin B1, Cyclin A, and Ki67, Alone
and in Combinations, in Node-Negative Premenopausal Breast Cancer. PLOS
ONE. Vol 8, No.2.
21.
Dahlan, dr. M. Sopiyudin. 2010. Langkah-Langkah Membuat Proposal
Penelitian Bidang Kedokteran dan Kesehatan. Jakarta : CV Agung Setyo.
22.
Sastroasmoro, Prof. Dr. Sudigdo dan Ismail, Prof. Dr. Sofyan. (2011). DasarDasar Metodologi Penelitian Klinis Edisi ke-4. Jakarta: Sagung Seto.
23.
National Cancer Institute Surveillance, Epidemiology, and End Results
Program. Sat Fact Sheet : Female Breasct Cancer [Internet]. 2013 [cited 2016
June 6]. Available from : http://seer.cancer.gov/statfacts/html/breast.html.
24.
Rahman, A., dkk. Hubungan Ekspresi HER-2/neu Dan Hormonal Reseptor
Dengan Grading Histopatologi Pada Penderita Kanker Payudara Usia Muda.
25.
Pradhiki, Muhammad. 2015. Profil Pasien Dan Ekspresi Protein HER-2/neu
Pada Wanita Di Laboratorium Patologi Anatomi Sentra Diagnostik Patologia
Makassar. Universitas Hasanuddin Makassar.
DAFTAR PUSTAKA
1.
Komite Nasional Penanggulangan Kanker (KPKN). 2015. Panduan Nasional
Penanganan Kanker Payudara. Kementrian Kesehatan Republik Indonesia.
2.
Anggorowati, Linda. 2013. Faktor Risiko Kanker Payudara Wanita. Jurnal
Kesehatan Masyarakat. Vol 8, No.2.
3.
Alteri, Rick. 2013. Breast Cancer Facts & Figures. Atlanta : Amercian Cancer
Society.
4.
Harianto. 2005. Risiko Penggunaan Pil Kontrasepsi Kombinasi Terhadap
Kejadian Kanker Payudara Pada Reseptor KB Di Perjan RS Dr. Cipto
Mangunkusumo. Majalah Ilmu Kefarmasian. Vol 2, No.1.
5.
Elisabet, Surbakti. 2013. Hubungan Riwayat Keturunan Dengan Terjadinya
Kanker Payu- dara Pada Ibu Di RSUP H . Adam Malik Medan The Relationship
Between Heredity And Incident Of Breast Can- cer Among Mothers At RSUP
H . Adam Malik , Medan.
6.
Kumar, V. dkk. 2013. Robbins Basic Pathology Edisi ke-9. Canada : Elsevier.
7.
Lakhani, S., dkk. 2012. WHO Classification of Tumours of the Breast.
International Agency for Research On Cancer.
8.
K. Anders, Carey, dkk. 2009. Breast Cancer Before Age 40 Years. NIH Public
Access Semioncol vol 36, pp. 237-49.
9.
Assi, Hussein A., dkk. 2013. Epidemiology and prognosis of breast cancer in
youg women. American University of Beirut Medical Center Lebanon.
35
10.
Rosai, J. 2011. Rosai And Ackerman Surgical Pathology 10th ed. Vol 2.
Philadelphia : Elseiver Sanders.
11.
Maru, D., dkk. 2005. HER-2 / neu and p53 Overexpression As Biomarkers of
Breast Carcinoma in Women Age 30 Years and Younger. American Cancer
Society.
12.
Han, W., dkk. 2004. Young age : an independent risk factor for survival in
women with operable breast cancer. BioMedCentral. Vol 4, No. 82.
13.
Constantines, Paris. 1994. General Pathobiology. Appleton & Lange.
14.
Duarsa, D.P., dkk. 2013. Faktor Risiko Kanker Payudara Pada Wanita di RSUP
Sanglah Denpasar. Denpasar : Universitas Udayana.
15.
Payne, S., dkk. 2008. Predictive markers in breast cancer - The Present.
16.
Your Guide to the Breast Cancer Pathology Report. Available From :
http://www.breastcancer.org/cms_files/47/Breastcancerorg_Pathology_Report_
Guide_2014.pdf.
17.
Upadana, I Nyoman. 2013. Ekspresi Cyclooxygenase-2 Berhubungan Positif
Dengan Derajat Diferensiasi Karsinoma Payudara Duktal Invasif Tipe Tidak
Spesifik. Universitas Udayana.
18.
Conzen, Suzanne D., Grushko, Tatyana A., dan Olopade, Olufunmilayo I. 2008.
Cancer of the Breast. Dalam DeVita, Vincent T., Lawrence, Theodore S., dan
Rosenberg, Steven A., Cancer Principles & Practice of Oncology Edisi ke-8.
Lippincott Williams & Wilkin.
19.
Nishimura, R., dkk. 2010. Ki-67 as a prognostic marker according to breast
36
cancer subtype and a predictor of recurrence time in primary breast cancer.
Experimental And Therapeutic Medicine. Vol 1, p 747-754.
20.
Klintmant, M. dkk. 2012. The Prognostic Value of Mitotic Activity Index
( MAI ), Phosphohistone H3 ( PPH3 ), Cyclin B1, Cyclin A, and Ki67, Alone
and in Combinations, in Node-Negative Premenopausal Breast Cancer. PLOS
ONE. Vol 8, No.2.
21.
Dahlan, dr. M. Sopiyudin. 2010. Langkah-Langkah Membuat Proposal
Penelitian Bidang Kedokteran dan Kesehatan. Jakarta : CV Agung Setyo.
22.
Sastroasmoro, Prof. Dr. Sudigdo dan Ismail, Prof. Dr. Sofyan. (2011). DasarDasar Metodologi Penelitian Klinis Edisi ke-4. Jakarta: Sagung Seto.
23.
National Cancer Institute Surveillance, Epidemiology, and End Results
Program. Sat Fact Sheet : Female Breasct Cancer [Internet]. 2013 [cited 2016
June 6]. Available from : http://seer.cancer.gov/statfacts/html/breast.html.
24.
Rahman, A., dkk. Hubungan Ekspresi HER-2/neu Dan Hormonal Reseptor
Dengan Grading Histopatologi Pada Penderita Kanker Payudara Usia Muda.
25.
Pradhiki, Muhammad. 2015. Profil Pasien Dan Ekspresi Protein HER-2/neu
Pada Wanita Di Laboratorium Patologi Anatomi Sentra Diagnostik Patologia
Makassar. Universitas Hasanuddin Makassar.